阿替洛尔在老年心力衰竭患者中的效果观察  

Effect of Atenolol in Elderly Patients with Heart Failure

作　　者：毕莎莎[1] BI Sha-sha(Department of Cardiology,Dalian Central Hospital,Dalian 116033,China)

机构地区：[1]大连市中心医院心内科

出　　处：《中国医药指南》2019年第29期4-5,共2页Guide of China Medicine

摘　　要：目的观察阿替洛尔治疗老年慢性心力衰竭患者的临床疗效。方法选取自2017年1月至2018年1月于大连市中心医院心内科收治的慢性心力衰竭病例60例,采用信封法随机分为试验组和对照组,其中对照组30例,采用西医吲哚普利、呋塞米、美托洛尔口服治疗的方法,试验组30例,吲哚普利、呋塞米、阿替洛尔口服观察两组患者的左心功能(LVEF)和B型尿钠肽(BNP)情况。结果试验组优于对照组,有统计学差异(P<0.05)。结论阿替洛尔治疗慢性心力衰竭可以提高患者心功能,降低BNP,临床效果显著,值得推广使用。Objective To observe the clinical efficacy of atenolol in the treatment of elderly patients with chronic heart failure(CHF).Methods 60 cases of chronic heart failure admitted from January 2017 to January 2018 in the Department of Cardiology of Dalian central hospital were randomly divided into experimental group and control group by envelope method.30 cases of the control group were treated with western medicine indopril,furosemide,metoprolol,30 cases in the experimental group,indopril and furasim.Atenolol was used to observe the left ventricular function(LVEF)and B type natriuretic peptide(BNP)in two groups.Results The experimental group was better than the control group,with statistical difference(P<0.05).Conclusion Atenolol can improve cardiac function and reduce BNP in patients with chronic heart failure.

关 键 词：阿替洛尔 慢性心力衰竭 临床观察 

分 类 号：R541.6[医药卫生—心血管疾病]